Anadromous arctic char (Salvelinus alpinus) undertake short feeding migrations to seawater every summer and accumulate lipids, while the rest of the year is spent in fresh water where the accumulated lipid reserves are mobilized. We tested the hypothesis that winter fasting and the associated polychlorinated biphenyls' (PCBs) redistribution from lipid depots to critical tissues impair the liver metabolic capacity in these animals. Char were administered Aroclor 1254 (0, 1, 10, and 100 mg/kg body mass) orally and maintained for 4 months without feeding to mimic seasonal winter fasting, while fed groups (0 and 100 mg Aroclor 1254/kg) were maintained for comparison. A clear dose-related increase in PCB accumulation and cytochrome P4501A (CYP1A) protein content was observed in the livers of fasted fish. This PCB concentration and CYP1A response with the high dose of Aroclor were 1.5-fold and 3-fold greater in the fasted than in the fed fish, respectively. In fed fish, PCB exposure lowered liver glycogen content, whereas none of the other metabolic indicators were significantly affected. In fasted fish, PCB exposure depressed liver glycogen content and activities of glucose-6-phosphate dehydrogenase, alanine aminotransferase, lactate dehydrogenase, and phosphoenolpyruvate carboxykinase and elevated 3-hydroxyacylcoA dehydrogenase activity and glucocorticoid receptor protein expression. There were no significant impacts of PCB on heat shock protein 70 (hsp70) and hsp90 contents in either fed or fasted fish. Collectively, our study demonstrates that winter emaciation associated with the anadromous lifestyle predisposes arctic char to PCB impact on hepatic metabolism including disruption of the adaptive metabolic responses to extended fasting.
Alarming levels of organochlorines, particularly polychlorinated biphenyls (PCBs), have been reported in the Arctic environment (De Wit et al., 2004) . Indeed, some of the highest tissue loads of PCBs have been reported in arctic animals including arctic char (Salvelinus alpinus; 5 mg/kg wet weight) from Bear Island (74°N) (Skotvold et al., 1998) . This high PCB accumulation in many arctic animals may be related to their distinct lifestyle, including dependency on lipids as energy resource. For instance, arctic environment is characterized by seasonal variations in food availability, and animals are adapted to this environment by accumulating lipid reserves during periods of high food availability (summer fattening) and mobilizing them during winter (winter emaciation). This is exemplified by anadromous arctic char that undertake short (6-9 weeks) seawater feeding migrations every summer, during which the body mass doubles and the lipid stores increase several fold (Jørgensen et al., 1997) . The rest of the year is spent in fresh water where the accumulated lipid reserves are mobilized to cope with energy demands including maturation and preparatory changes for seawater migration (Aas-Hansen et al., 2005; Jobling et al., 1998; Jørgensen et al., 1997) .
Consequently, the anadromous lifestyle predisposes them to PCB accumulation in lipid depots during fattening periods and redistribution of this lipophilic contaminant to other tissues including liver, gills, and brain during winter emaciation (Jørgensen et al., 2006) . Several studies have reported adverse effects associated with the redistribution of PCBs in fasted char, including altered stress response Jørgensen et al., 2002) and immune function (Maule et al., 2005) . However, very little is known about the impact associated with this toxicant accumulation on liver function, including cellular stress response and metabolism in piscine models. Indeed, our study showed inhibition of fasting-induced hyperglycemia by PCB (Jørgensen et al., 2002) , which prompted us to test the hypothesis that liver metabolic capacity is compromised by PCB exposure in fasted arctic char.
We mimicked PCB accumulation and mobilization, associated with fasting, by force-feeding a bolus of Aroclor 1254 and fasting the animal for 4 months in the winter (Jørgensen et al., 2002) . Aroclor 1254 was used as our model PCB because this technical mixture has a congener composition similar to that reported for fish in the Arctic (Muir et al., 1988) . Liver glycogen content and activities of phosphoenolpyruvate carboxykinase (PEPCK), aspartate aminotransferase (AspAT), alanine aminotransferase (AlaAT), lactate dehydrogenase (LDH), glucose-6-phosphate dehydrogenase (G6PDH), and 3-hydroxyacylcoA dehydrogenase (HOAD) were determined to assess the liver metabolic potential (Aas-Hansen et al., 2005) . Specifically, these enzymes were chosen to investigate PCB impact on liver capacity for gluconeogenesis (PEPCK), glycolysis (LDH), lipogenesis (G6PDH), lipid oxidation (HOAD), and amino acid catabolism (AspAT, AlaAT). In addition, cytochrome P4501A (CYP1A), glucocorticoid receptor (GR), heat shock protein 70 (hsp70), and hsp90 were measured as indicators of cellular stress response . Indeed, these proteins play a key role in the cellular defense against stressor insults including PCBs (Iwama et al., 1998; Vijayan et al., 2005) .
MATERIALS AND METHODS
Chemicals. Protease inhibitor cocktail, bicinchoninic acid (BCA) and benzocaine were obtained from Sigma (St. Louis, MO). All the electrophoresis reagents and molecular weight markers were from BioRad (Hercules, CA). Monoclonal mouse anti-cod CYP1A was obtained from Biosense Laboratories (Bergen, Norway). Polyclonal rabbit anti-trout GR was developed in our laboratory , while polyclonal rabbit anti-trout total hsp70 was obtained from Dr. Peter Candido (Biochemistry Department, University of British Columbia, Vancouver, BC, Canada). Monoclonal rat anti-human hsp90 antibody was obtained from StressGen (Victoria, BC). The secondary antibodies (IgG) were alkaline phosphatase conjugated with goat anti-rat for hsp90 (StressGen), goat anti-mouse for CYP1A, and goat anti-rabbit for GR and hsp70 (BioRad). Nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt (BCIP) were obtained from Fisher Scientific (Ottawa, ON).
Experimental protocol. The experimental protocol, including plasma cortisol, glucose, and lactate levels, has been published already (Jørgensen et al., 2002) . Briefly, char (aged 2.5 years) used in the experiment were fourthgeneration offsprings collected at Svalbard (79°N), and they were hatched and reared at the Kårvik Research Station, Tromsø, Norway. Prior to the start of the experiment in February, the fish were fed in excess daily according to standardized rearing procedures at the research station. Groups of 60 fish each (mean mass 234 g) were distributed into six circular tanks (500-l capacity) supplied with a continuous flow of fresh water (7°C), and the fish were maintained at 12L:12D photoperiod.
From February, fish from four tanks were fasted, while the other two groups were fed to satiety with pelleted (23% fat) commercial dry feed (Skretting, Stavanger, Norway) 5 days a week until sampling in July. In March, Aroclor 1254 (Promochem AB, Ulricehamn, Sweden) was force-fed to the fasted (0, 1, 10, and 100 mg/kg body mass) and fed groups (0 and 100 mg/kg body mass). We did not conduct a crossed design study because feeding is unnatural in the winter months for these fish. The fed groups were maintained only to compare the fasting effect on PCB accumulation in this species. PCB was administered in gelatin capsules containing Aroclor 1254 dissolved in cod liver oil, while the control fish were given capsules containing only oil (Jørgensen et al., 2002) . Fish were sampled 4 months after PCB exposure, and the sampling consisted of randomly netting 10 fish from each tank and quickly anesthetizing them with a lethal dose of benzocaine (300 ppm). The remaining fish in the tanks were used for the stress study (Jørgensen et al., 2002) . Body mass and liver weight for each fish were determined to calculate specific growth rate (SGR) and hepatosomatic index (HSI). Fish were sampled quickly, and liver samples were quickly collected and frozen on dry ice and stored at ÿ70°C for analyses of PCB concentration, stress-related proteins, glycogen content, and activities of enzymes involved in intermediary metabolism. Plasma collection method, as well as plasma cortisol and glucose levels in these fish, has already been published (Jørgensen et al., 2002) .
Liver PCB analysis. PCB analysis was carried out following the protocol previously described . Briefly, a small piece of liver sample was homogenized and extracted with acetone followed by hexane: acetone (3:1). After cleanup, PCB was determined by gas chromatography using an HRGC 5890 Series II (Fision Instruments S.p.A., Milano, Italy) equipped with a spitless injector, electron capture detector, and a highperformance HP-5 capillary column (50 m 3 0.20 lm 3 0.11 lm; HewlettPackard, Folsom, CA). The analyzed congeners (IUPAC numbers) including percentage recovery were: PCB 28-50%; PCB 31-51%; PCB 52-67%; PCB 99-54%; PCB 101-50%; PCB 105-69%; PCB 118-53%; PCB 138-63%; PCB 153-57%; PCB 156-80%; and PCB 180-72%.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. The liver CYP1A, GR, hsp70, and hsp90 were determined using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunodetection as explained below. The tissue total protein concentration was determined using the BCA method (Smith et al., 1985) with bovine serum albumin (BSA) as the standard. The procedure for SDS-PAGE and Western blotting were according to established protocols (Boone et al., 2002) . Briefly, 40 lg protein per sample was separated on 8% polyacrylamide gels using discontinuous buffer system (Laemmli, 1970) . The separated proteins were transferred onto nitrocellulose membrane (20 V for 30 min) with a semidry transfer unit (BioRad) using transfer buffer (25mM Tris pH 8.3, 192mM glycine, and 20% [vol/vol] methanol) and blocked with 5% skimmed milk in Tris buffered saline with Tween (TBS-t: 20mM Tris pH 7.5, 300mM NaCl, and 0.1% [vol/vol] Tween 20 with 0.02% sodium azide) for 60 min. Primary and secondary antibodies were diluted in the blocking solution to appropriate concentrations as indicated. The dilution for GR was 1:1000, while CYP1A, hsp70, and hsp90 were used at 1:3000. The secondary antibody, for all four proteins detection, was diluted to 1:3000 in blocking buffer. The membranes were incubated in primary antibody for 60 min at room temperature, washed with TBS-t (2 3 5 min), incubated with secondary antibody for 60 min, washed with TBS-t (2 3 5 min), and finally washed with TBS (1 3 15 min). Protein bands were detected with NBT (0.033% wt/ vol) and BCIP (0.017% wt/vol) and quantified with Chemi Imager using the AlphaEase software (Alpha Innotech, San Leandro, CA). The molecular mass of proteins was estimated using prestained low-range molecular weight markers (phosphorylase B 112 kDa, BSA 81 kDa, ovalbumin 49.9 kDa, carbonic anhydrase 36.2 kDa, soybean trypsin inhibitor 29.9 kDa, and lysozyme 21.3 kDa).
SGR, HSI, liver glycogen, and enzyme analyses. SGR (% per day) was calculated using the formula [(ln W T ÿ ln W t )/(T ÿ t) ÿ ] 3 100, where W T and W t are fish weights at the start and end of the experiment in February and July, respectively, and (T ÿ t) is the number of days between weighing. HSI was calculated from the formula, HSI ¼ liver mass 3 100/(body mass), where liver mass and body mass are in grams. Liver glycogen content was analyzed by liver glucose measurements before and after amyloglucosidase hydrolysis (Keppler and Decker, 1974) . For enzyme determinations, pieces of liver were homogenized (Ultra Turrax; IKA Works, Wilmington, NC) followed by sonication (Microson, Farmingdale, NY) in a 1:10 (wt/vol) buffer containing 21 mmol/l Na 2 HPO 4 , 5 mmol/l, 2-mercaptoethanol, 0.5 mmol/l EDTA, 0.2% BSA, 10 lg aprotininÁm/l, and 50% (vol/vol) glycerol, and pH was adjusted to 7.4. The average protein concentration in the homogenate was 4 mg/ml, and the sample volume (ranging from 0.1 to 10 ll in a total of 250 ll reaction mixture) for each enzyme activity measurement was determined after preliminary testing. Liver enzyme activities were measured in 50 mmol/l imidazolebuffered (pH 7.4) assay buffer in a final volume of 250 ll at 22°C by continuous spectrophotometry at 340 nm on a microplate reader (VersaMax; Molecular Devices Corp., Palo Alto, CA). The enzymes and assay conditions (found to give optimal activities) used have been described before (Aas-Hansen et al., 2005) .
Alanine aminotransferase (AlaAT: EC 2.6.1.2): 0.12 mmol/l reduced form of NADH, 200 mmol/l L-alanine, 0.025 mmol/l pyridoxal 5-phosphate, 10.5 mmol/l a-ketoglutarate, and 3 units of LDH.
Aspartate aminotransferase (AspAT: EC 2.6.1.1): 40 mmol/l aspartate, 7 mmol/l a-ketoglutarate, 0.025 mmol/l pyridoxal 5-phosphate, 0.12 mmol/l NADH, and 2 units of malate dehydrogenase.
Glucose-6-phosphate dehydrogenase (G6PDH: EC 2.6.1.1): 7 mmol/l MgCl 2 , 1 mmol/l glucose-6-phosphate, and 0.4 mmol/l b-NADP.
3-hydroxyacylcoA dehydrogenase (HOAD: EC 1.1.1.35): 0.05 mmol/l acetoacetyl-coenzyme A, and 0.05 mmol/l NADH.
Lactate dehydrogenase (LDH: EC 1.1.1.27): 1 mmol/l pyruvate and 0.12 mmol/l NADH.
Phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32): 20 mmol/l NaHCO3, 1 mmol/l MnCl 2 , 0.5 mmol/l phosphoenolpyruvate, 0.2 mmol/l deoxyguanosine diphosphate, and 0.12 mmol/l NADH.
The enzyme activity represents micromoles of substrate consumed or product liberated per minute (U) per gram protein in the homogenate.
Statistical analysis. Statistical analysis was performed with SPSS version 11.5 (SPSS Inc., Chicago, IL), and data were expressed as means ± SEMs. The data were transformed (logarithmic), wherever necessary, for homogeneity of variance, but nontransformed values are shown in the figures. One-way ANOVA was used to compare treatment effects, and wherever significant differences were observed, Bonferroni's post hoc test was used for pairwise comparison. A probability level of p < 0.05 was considered significant.
RESULTS

SGR and HSI
Fasting resulted in a negative SGR that was significantly different from the fed char (Table 1) , and it also reduced HSI compared to the fed fish. However, PCB exposure did not modify either SGR or HSI in the fasted and fed char (Table 1) .
PCB Concentration
PCB accumulation in the liver of fasted fish showed a significant dose-related increase with PCB exposure. The PCB concentration in the control groups was either very low or undetectable. The PCB concentration in the medium-and highdose groups was approximately 8-fold and 70-fold higher, respectively, compared to the low PCB group (Fig. 1A) . Among the fed fish, the high-dose PCB group had a significantly higher PCB concentration compared with fed control. However, the PCB concentration in the liver of fasted fish treated with high PCB was 1.5-fold higher than that seen in the fed fish given similar dosage (Fig. 1A) .
CYP1A Protein
In the fasted group, there was a significant dose-related increase in the liver CYP1A protein content with PCB (Fig. 1B) , while the medium PCB group was not statistically different from the high PCB group (Fig. 1B) . There was also a significant higher liver CYP1A content in fed group treated with PCB compared with control fed group (Fig. 1B) . However, the liver CYP1A content in the high PCB-treated fasted fish was threefold greater than the fed group (Fig. 1B) .
Plasma Glucose and Liver Glycogen Content
Plasma glucose levels were significantly higher with fasting compared to the fed arctic char. PCB exposure significantly FIG. 1. Liver PCB concentration and CYP1A protein expression. Aroclor 1254 was administered to either fasted (0, 1, 10, and 100 mg/kg body mass) or fed (0 and 100 mg/kg body mass) arctic char, and livers were sampled 4 months later for PCB concentration (A) and CYP1A protein expression (B; inset shows a representative Western blot). CYP1A protein was immunodetected using mouse monoclonal anti-cod CYP1A antibody; values represent means þ SEMs (PCB: n ¼ 3; CYP1A: n ¼ 5-6); different letters denote significant treatment effects (one-way ANOVA, p < 0.05). PCB IMPACTS ARCTIC CHAR LIVER 433 depressed plasma glucose levels in the fasted, but not fed, char (Jørgensen et al., 2002, Fig. 2A ). Liver glycogen content was significantly lower with fasting compared to fed char (Fig. 2B) . There was no significant difference in glycogen content in the low and medium PCB groups compared to the control groups in the fasted fish. However, high PCB group had significantly lower glycogen content compared to all other groups, except the low PCB group, in the fasted char. Also, high PCB significantly lowered glycogen content compared to the control group in the fed fish (Fig. 2B) .
Enzyme Activities
The liver LDH (glycolytic enzyme) activity was significantly elevated with fasting compared to the fed fish (Fig. 3A) . This fasting-induced LDH activity was significantly inhibited by all three PCB doses (Fig. 3A) . PCB exposure had no significant impact on LDH activity in the fed fish (Fig. 3A) . Fasting did not significantly affect PEPCK (gluconeogenic) activity compared to the fed char (Fig. 3B) . High PCB exposure, but not the low and medium dose, significantly depressed PEPCK activity compared to all other groups in the fasted fish but not in the fed fish (Fig. 3B) .
Fasting significantly elevated liver AlaAT, but not AspAT (enzymes involved in amino acid catabolism), activities compared to the fed fish (Figs. 4A and 4B ). All three PCB doses significantly inhibited this fasting-induced AlaAT activity, while in the fed group PCB did not affect this enzyme activity (Fig. 4A) . Also, low PCB exposure, but not the medium-or highdose exposure, depressed AspAT activity in the fasted fish compared to the fed fish (Fig. 4B) , while no significant impact of PCB on AspAT activity was noted in the fed fish (Fig. 4B) .
Fasting per se had no significant effect on the activities of either the lipolytic (HOAD: b-oxidation) or the lipogenic (G6PDH) enzymes compared to the fed char (Figs. 5A and 5B). All PCB doses significantly elevated HOAD activity in the fasted char, while no significant effect of PCB on this lipolytic enzyme activity was seen in the fed fish (Fig. 5A) . The G6PDH activity was significantly depressed at all doses of PCB in the fasted fish, while no such response to PCB was observed in the fed fish (Fig. 5B) .
GR, Hsp70, and Hsp90
Fasting per se had no significant effect on liver GR and hsp70 contents, whereas hsp90 content was significantly depressed compared to the fed fish (Figs. 6, 7A , and 7B, respectively). In the fasted fish, high PCB dose, but not the other doses, significantly elevated GR protein expression compared to the control group, while no such PCB effect was observed in the fed group (Fig. 6 ). There was no significant effect of PCB treatment on liver hsp70 and hsp90 expressions in either fed or fasted char (Figs. 7A and 7B ).
DISCUSSION
Our study demonstrates for the first time that extended fasting, associated with the anadromous lifestyle, predisposes arctic char to PCB-mediated disruption of liver metabolism. The short annual feeding cycle and the associated high degree of lipid deposition in this northernmost-living salmonid facilitates accumulation of lipophilic contaminants, while the extended winter fasting mobilizes lipids and redistributes the contaminants from lipid depots to critical tissues, including liver, gills, and brain (Jørgensen et al., 2006) . Indeed, this PCB redistribution impacts animal performance, including impaired stress (Jørgensen et al., 2002) and immune responses (Maule et al., 2005) , as well as a decreased capacity for seawater tolerance, growth, and survival (Jørgensen et al., 2006) . The liver PCB concentrations reported here, even with high Aroclor 1254 (100 mg/kg) administration, are not unlike the tissue PCB burdens reported for feral char from Bear Island (Jørgensen et al., 2006) . As liver metabolic reorganization is crucial for coping with winter emaciation as well as seawater migration the following year (Aas-Hansen et al., 2005), our study underscores the potential impact of PCB in disrupting this 
Metabolic Adjustments to Fasting
Anadromous lifestyle of arctic char involves unique adaptive strategies, including endocrine and metabolic adjustments (Aas-Hansen et al., 2005; Jørgensen et al., 2002) , to cope with extended fasting. Indeed, we proposed hyperglycemia and elevated plasma cortisol concentrations as adaptive responses associated with fasting in this species (Jørgensen et al., 2002) . Plasma glucose is an important fuel for metabolism (Mommsen et al., 1999; Moon, 2001) , and in the absence of feeding, the plasma levels of this metabolite are maintained by either liver glycogenolysis and/or gluconeogenesis (Mommsen et al., 1999) . Our finding of lower liver glycogen content coupled with elevated plasma glucose levels with fasting supports enhanced glycogenolysis ( Figs. 2A and  2B ), while the higher liver LDH activity with fasting also suggests an enhanced glycolytic potential, providing ATP for hepatic function. Therefore, it is likely that both these processes are involved in reducing liver glycogen content with long-term fasting in salmonids (Pereira et al., 1995b) . Nonetheless, liver glycogen content in fasted char was maintained at > 50% of fed levels even after a 5-month fasting (Fig. 2B) , supporting the notion that this energy reserve is conserved to provide glucose to critical tissues especially in response to increased energy demand associated with stress (Pereira et al., 1995b) . While the utilization of circulating glucose by fish liver for glycogen repletion is not clear (Moon, 2001 ) certainly gluconeogenesis from amino acids have been shown to contribute to glycogen repletion in fasted hepatocytes (Pereira et al., 1995a) . Together, these results suggest conservation and/or repletion of liver glycogen stores in fasting salmonids, and this process is thought to involve enhanced liver capacity for gluconeogenesis (Pereira et al., 1995a,b) .
While liver PEPCK activity (an indicator of gluconeogenic capacity) showed no significant change in fasted char, the nearly fourfold increase in AlaAT activity (a key enzyme involved in amino acid catabolism and providing C3 substrates for gluconeogenesis) supports an enhanced liver gluconeogenic capacity. Also, the activities of transaminases, rather than PEPCK, are thought to be a more reliable measure of tissue gluconeogenic capacity in teleosts (Mommsen et al., 1999; Vijayan et al., 2003) . The negative SGR observed in fasted fish implies enhanced peripheral proteolysis, and it is well established that mobilized amino acids from peripheral stores are preferred substrates for gluconeogenesis in teleosts (French FIG. 6 . Liver GR protein expression. Aroclor 1254 was administered to either fasted (0, 1, 10, and 100 mg/kg body mass) or fed (0 and 100 mg/kg body mass) arctic char and liver sampled 4 months later for GR determination. A representative Western blot is shown above the histogram; GR was immunodetected using rabbit polyclonal anti-trout GR antibody; values represent means þ SEMs (n ¼ 5-6); different letters denote significant treatment effects (one-way ANOVA, p < 0.05).
FIG. 7.
Liver hsp70 and hsp90 expression. Aroclor 1254 was administered to either fasted (0, 1, 10, and 100 mg/kg body mass) or fed (0 and 100 mg/kg body mass) arctic char and liver sampled 4 months later for hsp70 (A) and hsp90 (B) determination. A representative Western blot is shown above the respective histograms; hsp70 was immunodetected using rabbit polyclonal antitrout hsp70, while hsp90 was detected with a rat monoclonal anti-human hsp90 antibody; values represent means þ SEMs (n ¼ 5-6); different letters denote significant treatment effects (one-way ANOVA, p < 0.05).
et al., 1981; Mommsen, 2004; Mommsen et al., 1999; Saurez and Mommsen, 1987) . Also, elevated plasma cortisol levels seen with fasting in arctic char (Jørgensen et al., 2002) support this contention as this corticosteroid is a key regulator of plasma glucose levels in teleosts. The mode of action of cortisol in the hyperglycemic response is thought to involve the enhancement of liver capacity for gluconeogenesis (Mommsen et al., 1999) as well as mobilization of amino acids from peripheral stores for gluconeogenesis (Milligan, 1997; Mommsen, 2004; Mommsen et al., 1999) . Considered together, maintenance of liver glycogen content, albeit at a reduced level, by enhanced liver capacity for gluconeogenesis appears to be important adaptive strategies during winter emaciation in arctic char and may be hormonally regulated (Aas-Hansen et al., 2005; Jørgensen et al., 2006) .
PCB Impact
We show for the first time that hepatic function is particularly sensitive to PCB exposure in anadromous char during winter emaciation. Most of the metabolic changes were evident even at the lowest dose of PCB in the fasted fish, while a similar impact even at a higher PCB concentration was not seen in the fed fish, implicating a role for nutritional status of the animal in modulating PCB toxicity. Indeed, the liver loading of PCB was also influenced by the nutritional state of the animal in the present study (Fig. 1A) and supports the redistribution of this lipophilic contaminant from lipid depots to critical tissues including brain and liver with fasting in char (Jørgensen et al., 2006, Fig. 1A) . As liver metabolic reorganization, including energy repartitioning, is a critical part of the adaptive strategy for extended fasting and seawater migration in anadromous arctic char (Aas-Hansen et al., 2005) , this PCB accumulation in the liver may impair the adaptive metabolic response. The mode of action of PCBs may involve a direct impact on enzyme activities or impact indirectly by impinging on the tissue energy budget of the animal (Vijayan et al., 1997) .
The indirect effect on metabolic capacity is supported by the significant dose-related elevation of CYP1A protein content with PCB, suggesting a greater tissue demand for energy in response to this protein synthesis. The upregulation of CYP1A protein synthesis is a well-established response to PCBs binding to aryl hydrocarbon receptor (AhR) and activation of this transcription factor in fish (Hahn, 1998) . Clearly, the threefold greater CYP1A protein content in the liver of fasted char compared to fed fish indicates an increased liver energy demand in winter-emaciated char to cope with PCB exposure. This demand may be met by enhanced lipolysis (HOAD), while a diminished lipogenic capacity (G6PDH) points to an overall shift to lipid catabolism with PCB stimulation in fasted char liver (Figs. 5A and 5B). Also, the significantly depressed liver glycogen content in the highest PCB dose compared to the medium PCB group, without any associated changes in plasma glucose concentration ( Figs. 2A and 2B ), supports increased glycolytic potential that may be related to the high toxicant exposure (greater than eightfold PCB levels compared to the medium dose [ Fig. 1A]) . Consequently, the increased tissue metabolic demands, including ATP requirements for synthesis of critical proteins such as CYP1A, in the fasted liver may lead to suppression of other energy-demanding pathways including gluconeogenesis (Vijayan et al., 1997) .
Indeed, inhibition of the fasting-induced hyperglycemic response by PCB in arctic char (Jørgensen et al., 2002) supports the above notion as gluconeogenesis is thought to maintain elevated plasma glucose levels with fasting. Also, the significantly lower liver PEPCK activity with the high PCB dose points to this key gluconeogenic enzyme as a target for PCB toxicity. Our results are in agreement with mammalian studies, showing clearly that PCBs impair glucose metabolism by depressing the transcript level (Stahl et al., 1993) and activity of PEPCK (Stahl, 1995; Stahl et al., 1993; Viluksela et al., 1995 Viluksela et al., , 1999 Weber et al., 1995) . However, PCB impact on PEPCK activity was evident only at the high dose, but not the low or medium dose, whereas fasting-induced AlaAT activity was inhibited by all PCB doses, leading to the proposal that AlaAT is more sensitive than PEPCK to PCB toxicity in this species. As amino acids, especially alanine, are preferred substrates for gluconeogenesis in fish (French et al., 1981; Milligan, 1997; Mommsen et al., 1999) , the lower AlaAT activity with PCBs implicates a reduced liver capacity for amino acid catabolism and gluconeogenesis. As gluconeogenesis is playing a key role in maintaining hyperglycemia with fasting, the depression in the liver gluconeogenic capacity with PCB may be a key factor in the reduced plasma glucose levels observed in the PCB group with fasting (Jørgensen et al., 2002) . This reduction in liver capacity for gluconeogenesis may also be contributing to the lower glycogen levels seen in the high PCB group, especially since the lower liver LDH activities with PCB treatment argue against glycolysis as a factor for the reduced liver glycogen content. However, the depression in liver glycogen content with PCB also in the fed fish raises the possibility that PCB may directly compromise liver glycogen synthesis in this species. Considered together, glycogen synthetic pathway and gluconeogenic pathway, contributing to maintaining elevated plasma glucose levels and repleting liver glycogen stores in fasting arctic char, are targets for PCB impact. The mode of action of PCBs may involve either direct inhibition of key enzymes in the pathway, as seen with gluconeogenic inhibition by PCBs in mammalian models (Stahl, 1995; Stahl et al., 1993; Viluksela et al., 1995 Viluksela et al., , 1999 Weber et al., 1995) , or inhibit indirectly by impacting key modulators of enzyme activity.
For instance, a key regulator of liver gluconeogenic capacity is cortisol (Mommsen et al., 1999) , and resting levels of this hormone were elevated with extended fasting in char (Jørgensen et al., 2002) . However, PCBs abolished this fastinginduced cortisol response PCB IMPACTS ARCTIC CHAR LIVER 2002), leading to the hypothesis that the impaired gluconeogenic capacity with PCB may also be indirectly related to either impaired cortisol levels and/or target tissue glucocorticoid signaling Jørgensen et al., 2002) . To this end, despite a lack of change in plasma cortisol levels in the PCB groups, the highest PCB dosage did result in a significantly higher GR protein content, suggesting a threshold level for PCB impact on glucocorticoid signaling . A similar increase in liver GR protein content in response to AhR agonist treatment was reported in rainbow trout . The lack of GR response to PCB in the fed fish (lower total PCB concentration compared to fasted liver) supports a higher tissue PCB threshold for GR upregulation, but the interaction of nutritional status of the animal on this PCB-mediated GR response cannot be ruled out and awaits further study.
Despite the elevated GR levels in fasted fish with high PCB exposure, the lack of recovery in liver gluconeogenic capacity or plasma glucose levels in this group, reflecting enhanced tissue responsiveness to this glucocorticoid, suggests a disruption of corticosteroid signaling by PCBs . Whether this increase in GR contents in the high PCB group, but not the low or medium groups, is just compensatory response to reduced tissue exposure to cortisol, as proposed before for trout , remains to be verified. The lack of any impact of PCB on liver hsp70 and hsp90 content, two molecular chaperones crucial for cellular defense against stressors and also involved in GR signaling (Basu et al., 2001; Iwama et al., 1998; Vijayan et al., 2005) , suggests that the PCB-mediated disruption of metabolism is distinct from the overall cellular stress response. This is contrary to our finding in arctic char brain, which clearly showed a reduced GR, hsp70, and hsp90 content with high PCB and correlated with impaired cortisol response to stress , underpinning the tissue-specific responses to PCB in this species.
In conclusion, extended fasting, associated with the anadromous lifestyle of arctic char, enhances PCB accumulation in the liver of arctic char. This PCB exposure impacts the adaptive metabolic response that is crucial for coping with extended fasting in this species. Specifically, PCB exposure in fasted fish increased liver capacity for fatty acid oxidation, while depressing gluconeogenic and lipogenic capacities. Our results suggest impairment of liver responsiveness to glucocorticoid stimulation at a higher PCB threshold, whereas disruption of liver metabolic capacity was evident even at very low and environmentally realistic PCB concentrations. Overall, seasonal cycles of short feeding periods and extended fasting, unique to the arctic environment, coupled with the high deposition of organic contaminants in this ecosystem predisposes arctic wildlife to PCB impact on hepatic function. The minimal metabolic response to PCB in fed char, despite the high liver PCB concentration, underscores the important role nutritional status of the animal plays in modulating PCB toxicity.
